Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLBT
CLBT logo

CLBT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
12.980
Open
12.420
VWAP
12.68
Vol
4.43M
Mkt Cap
3.20B
Low
12.220
Amount
56.16M
EV/EBITDA(TTM)
31.16
Total Shares
249.44M
EV
2.77B
EV/OCF(TTM)
16.06
P/S(TTM)
6.48
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
Show More

Events Timeline

(ET)
2026-05-14
07:20:00
Sees 2026 Adjusted EBITDA of $149M-$155M
select
2026-05-14
07:10:00
Cellebrite Q1 Revenue $128.3M Exceeds Expectations
select
2026-05-14
07:10:00
Sees Q2 Adjusted EBITDA of $29M-$31M
select
2026-05-06 (ET)
2026-05-06
08:50:00
Cellebrite Government Cloud Achieves FedRAMP High Authorization
select
2026-03-16 (ET)
2026-03-16
08:50:00
Cellebrite Launches Revolutionary AI Product Genesis
select

News

PRnewswire
8.5
06-11PRnewswire
Cellebrite Genesis Launches, Revolutionizing Investigation Efficiency
  • Efficiency Boost: The launch of Cellebrite Genesis enables investigators to analyze digital evidence in minutes rather than days or weeks, significantly enhancing responsiveness to the rising tide of cybercrime.
  • Surging Market Demand: According to the FBI's 2025 Internet Crime Report, Americans suffered nearly $21 billion in losses due to cybercrime, with AI-related fraud losses nearing $900 million, highlighting the urgent need for AI-driven investigative tools.
  • Positive User Feedback: Since March 2026, Genesis has been utilized by over 800 users and 300 law enforcement agencies globally, with users reporting that analysis workloads that previously took weeks can now be completed in under an hour, and in some cases, less than 15 minutes.
  • Feature Expansion and Security: The general availability of Genesis will include feature enhancements based on early user feedback while ensuring customer data security and privacy, with no data retained for model training, thus maintaining the integrity and reliability of investigations.
PRnewswire
3.5
06-11PRnewswire
Cellebrite Genesis Launches, Enhancing Investigation Efficiency
  • Efficiency Boost: The launch of Cellebrite Genesis enables investigators to quickly analyze digital evidence in minutes, significantly reducing work time from weeks to minutes, thereby enhancing responsiveness to increasingly complex cybercrimes.
  • Surging Market Demand: According to the FBI's 2025 Internet Crime Report, Americans lost nearly $21 billion to cybercrime, with AI-related fraud losses nearing $900 million, highlighting the urgent need for AI-driven investigative tools.
  • Positive User Feedback: Since March 2026, Genesis has been in early access with over 800 users and 300 agencies, reporting that analytical workloads that previously took weeks are now completed in one hour, and in some cases, under 15 minutes, greatly improving case processing efficiency.
  • Global Availability Expansion: Cellebrite Genesis is now available to state and local government clients in North America, with plans to extend availability to international markets and the private sector by 2026, further advancing the intelligent evolution of global digital investigations.
PRnewswire
3.5
06-11PRnewswire
Cellebrite Genesis Accelerates Digital Evidence Analysis
  • Efficiency Boost: Cellebrite Genesis leverages AI technology to reduce investigation time from weeks to minutes, enabling investigators to quickly analyze digital evidence and significantly enhance their ability to tackle increasingly complex cybercrime.
  • Growing Market Demand: According to the FBI's 2025 Cybercrime Report, Americans lost nearly $21 billion due to cybercrime, highlighting the urgent need for efficient investigative tools, with Genesis perfectly positioned to fill this market gap.
  • Positive User Feedback: Since its early access launch in March 2026, Genesis has attracted over 800 users and 300 agencies, with feedback indicating that analysis time has been reduced from weeks to just 15 minutes, greatly improving case handling efficiency.
  • Global Availability Expansion: Cellebrite Genesis is now widely deployed in North American public agencies, with plans for further expansion into international markets and the private sector in 2026, enhancing global digital investigation capabilities.
PRnewswire
8.5
06-10PRnewswire
Cellebrite Genesis Launches, Revolutionizing Investigation Efficiency
  • Efficiency Boost: The launch of Cellebrite Genesis allows investigators to reduce investigation times from weeks to minutes, leveraging its AI capabilities to quickly analyze digital evidence, significantly enhancing responsiveness to increasingly complex digital crimes.
  • Data Processing Capability: The system can natively analyze over 35 evidence formats, including call detail records and documents, enabling investigators to swiftly identify key evidence, thereby improving case progression efficiency.
  • Positive User Feedback: Since March 2026, over 800 users and 300 agencies have participated in early access, with users reporting that analytical workloads have been reduced from weeks to one hour, and in some cases, even completed in under 15 minutes, greatly accelerating case handling speed.
  • Market Expansion Plans: Cellebrite Genesis is now generally available for state and local government customers in North America, with plans to expand to international and private sectors by 2026, further solidifying its leadership position in the digital investigative field.
Newsfilter
3.5
06-10Newsfilter
Cellebrite Genesis Launches, Revolutionizing Investigation Efficiency
  • Efficiency Boost: The launch of Cellebrite Genesis enables investigators to analyze digital evidence in minutes, significantly reducing investigation times and addressing the growing demand for digital crime solutions, which is expected to accelerate case processing speeds.
  • Data Processing Capability: The system can natively analyze over 35 evidence formats, with customers reporting that analytical workloads that once took weeks are now completed in an hour, and in some cases, even under 15 minutes, greatly enhancing operational efficiency.
  • User-Driven Enhancements: The expansion of Genesis's features is directly shaped by early user feedback, including upgraded media analysis and location intelligence, ensuring investigators can work efficiently within legal parameters, thereby enhancing compliance in case handling.
  • Market Demand Response: With the rise of cybercrime and AI-enabled scams, the launch of Cellebrite Genesis meets the urgent market need for efficient investigative tools, which is expected to attract more attention from law enforcement agencies and enterprise customers.
PRnewswire
1.0
06-05PRnewswire
Cellebrite to Participate in Investor Events
  • Investor Event Schedule: Cellebrite plans to participate in two investor events on June 10, 2026, namely the Cellebrite AI Technology Talk and the Mizuho Technology Conference, showcasing its latest AI technologies in the digital investigation sector.
  • Technology Platform Introduction: During the Cellebrite AI Technology Talk, the company will provide an in-depth look at its newly launched Genesis platform, which aims to enhance investigative efficiency through AI technology, potentially attracting more customer interest in its offerings.
  • Market Trust Enhancement: Cellebrite's AI-driven software is utilized by over 7,000 law enforcement agencies and enterprises globally, supporting nearly 3 million legally sanctioned investigations annually, highlighting its significance in public safety and data accessibility.
  • Diverse Deployment Capabilities: Cellebrite's technology is available in cloud, on-premises, and hybrid environments, enhancing operational flexibility for its clients across various scenarios, thereby improving overall business efficiency and market competitiveness.
Wall Street analysts forecast CLBT stock price to rise
7 Analyst Rating
Wall Street analysts forecast CLBT stock price to rise
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
23.00
Averages
24.83
High
28.00
Current: 0.000
sliders
Low
23.00
Averages
24.83
High
28.00
DA Davidson
Buy
initiated
$20
AI Analysis
2026-05-26
Reason
DA Davidson
Price Target
$20
AI Analysis
2026-05-26
initiated
Buy
Reason
DA Davidson initiated coverage of Cellebrite with a Buy rating and $20 price target. The company's total addressable market is large, growing, and likely understated, the analyst tells investors in a research note. The stock also offers multiple drivers of continued wallet share gains and achievement of guided to organic annualized recurring revenue growth acceleration, the firm added.
Needham
Buy
downgrade
$18 -> $15
2026-05-15
Reason
Needham
Price Target
$18 -> $15
2026-05-15
downgrade
Buy
Reason
Needham lowered the firm's price target on Cellebrite to $15 from $18 and keeps a Buy rating on the shares. The company's Q1 results outperformed consensus estimates across the board, though the firm is reducing its price target to reflect multiple compression, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CLBT
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cellebrite DI Ltd (CLBT.O) is 35.71, compared to its 5-year average forward P/E of 45.97. For a more detailed relative valuation and DCF analysis to assess Cellebrite DI Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
45.97
Current PE
35.71
Overvalued PE
69.26
Undervalued PE
22.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
28.95
Current EV/EBITDA
48.51
Overvalued EV/EBITDA
40.88
Undervalued EV/EBITDA
17.01

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
5.64
Current PS
4.80
Overvalued PS
7.97
Undervalued PS
3.31

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best swing trades $10-$20
Intellectia · 209 candidates
Price: $10.00 - $20.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $-5.00 - $15.00Macd: bullish
Ticker
Name
Market Cap$
top bottom
CLBT logo
CLBT
Cellebrite DI Ltd
3.79B
AEVA logo
AEVA
Aeva Technologies Inc
901.80M
SPMC logo
SPMC
Sound Point Meridian Capital Inc
217.22M
NAVN logo
NAVN
Navan Inc
2.58B
GPRE logo
GPRE
Green Plains Inc
1.06B
UMAC logo
UMAC
Unusual Machines Inc
559.45M
let me seethedaytrading stocks
Intellectia · 41 candidates
Price: $5.00 - $50.00Relative Vol: >= 2Beta: HighRiskWeekly Average Turnover: >= 2,000,000
Ticker
Name
Market Cap$
top bottom
NEOV logo
NEOV
NeoVolta Inc
191.06M
CNTA logo
CNTA
Centessa Pharmaceuticals PLC
3.39B
ZURA logo
ZURA
Zura Bio Ltd
410.95M
IPI logo
IPI
Intrepid Potash Inc
456.52M
DCOM logo
DCOM
Dime Community Bancshares Inc
1.44B
CLBT logo
CLBT
Cellebrite DI Ltd
3.85B
find stock with increasing volume
Intellectia · 114 candidates
Market Cap: 500.00M - 5.00BRelative Vol: >= 2
Ticker
Name
Market Cap$
top bottom
PLXS logo
PLXS
Plexus Corp
4.86B
MIRM logo
MIRM
Mirum Pharmaceuticals Inc
4.82B
IEP logo
IEP
Icahn Enterprises LP
4.81B
SFBS logo
SFBS
ServisFirst Bancshares Inc
4.78B
RUSHB logo
RUSHB
Rush Enterprises Inc
4.68B
TCBI logo
TCBI
Texas Capital Bancshares Inc
4.67B
what stock is bearish today
Intellectia · 65 candidates
Relative Vol: >= 2Moving Average Relationship: PriceBelowMA20Candlestick Pattern: BlackCandlestickWeek Price Change Pct: <= $-3.00Support Resistance Relationship: PriceFallBelowSupport
Ticker
Name
Market Cap$
top bottom
ABT logo
ABT
Abbott Laboratories
209.93B
SHOP logo
SHOP
Shopify Inc
180.36B
NET logo
NET
Cloudflare Inc
59.54B
SRE logo
SRE
Sempra
56.12B
BR logo
BR
Broadridge Financial Solutions Inc
24.15B
EQH logo
EQH
Equitable Holdings Inc
13.11B

Whales Holding CLBT

P
Portolan Capital Management, LLC
Holding
CLBT
+39.36%
3M Return
G
Granahan Investment Management, LLC
Holding
CLBT
+23.64%
3M Return
V
Voss Capital, LP
Holding
CLBT
+21.12%
3M Return
C
Clal Financial Management Ltd
Holding
CLBT
+17.39%
3M Return
M
Migdal Mutual Funds Ltd.
Holding
CLBT
+16.80%
3M Return
M
Meitav Investment House Ltd
Holding
CLBT
+14.09%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cellebrite DI Ltd (CLBT) stock price today?

The current price of CLBT is 12.83 USD — it has increased 2.89

What is Cellebrite DI Ltd (CLBT)'s business?

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.

What is the price predicton of CLBT Stock?

Wall Street analysts forecast CLBT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLBT is24.83 USD with a low forecast of 23.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cellebrite DI Ltd (CLBT)'s revenue for the last quarter?

Cellebrite DI Ltd revenue for the last quarter amounts to 128.30M USD, increased 19.30

What is Cellebrite DI Ltd (CLBT)'s earnings per share (EPS) for the last quarter?

Cellebrite DI Ltd. EPS for the last quarter amounts to 0.04 USD, decreased -42.86

How many employees does Cellebrite DI Ltd (CLBT). have?

Cellebrite DI Ltd (CLBT) has 1285 emplpoyees as of June 20 2026.

What is Cellebrite DI Ltd (CLBT) market cap?

Today CLBT has the market capitalization of 3.20B USD.